Accessibility Menu
 
Wesana Health logo

Wesana Health

(OTC) WSNAF

Current Price$0.00
Market CapN/A
Since IPO (2021)-100%
5 Year-100%
1 Year-100%
1 Month-100%

Wesana Health Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$1.18M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-785.71 (Low)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.08

WSNAF News

No articles available.

WSNAF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wesana Health

Industry

Pharmaceuticals

CEO

Daniel Carcillo

Headquarters

Chicago, IL 60607, US

WSNAF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

4%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

20.92M

Volume

200

Short Interest

0.00%

Avg. Volume

2.53K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.12M

EBITDA

$1.89M

Operating Cash Flow

$865.31K

Capital Expenditure

$0.00

Free Cash Flow

$865.31K

Cash & ST Invst.

$269.67K

Total Debt

$248.72K

Wesana Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

7

N/A

Net Income

$36.67K

-105.9%

EBITDA

$33.05K

+96.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$203.07K

-147.1%

Accounts Receivable

$50.92K

-94.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$250.00K

+0.0%

Return on Assets

-1.77%

N/A

Return on Invested Capital

4.13%

N/A

Free Cash Flow

$16.68K

+93.2%

Operating Cash Flow

$16.68K

+93.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RASPActavia Life Sciences, Inc.
$0.00+0.00%
CHNXFChitogenX Inc.
$0.01+0.00%
NBIONascent Biotech, Inc.
$0.00+0.00%
RGBPRegen BioPharma, Inc.
$0.00-14.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About WSNAF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.